换一批A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy.
第一作者：
W C,Jackson
第一单位：
University of Michigan, Department of Radiation Oncology, United States.
作者：
医学主题词
老年人(Aged);癌, 肝细胞(Carcinoma, Hepatocellular);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);辐射损伤(Radiation Injuries);放射外科手术(Radiosurgery);放射治疗剂量(Radiotherapy Dosage);治疗结果(Treatment Outcome)
DOI
10.1016/j.radonc.2019.07.027
PMID
31431377
发布时间
2021-03-15
- 浏览0
Radiotherapy and oncology
101-107页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
